14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.94 $4.15 Thursday, 25th Apr 2024 CLRB stock ended at $3.02. This is 1.31% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.37% from a day low at $2.94 to a day high of $3.10.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Aug 18, 2021 $0.88 $0.89 $0.85 $0.87 1 429 834
Aug 17, 2021 $0.87 $0.91 $0.85 $0.88 653 521
Aug 16, 2021 $0.87 $0.93 $0.85 $0.90 1 617 535
Aug 13, 2021 $0.86 $0.88 $0.84 $0.87 947 484
Aug 12, 2021 $0.92 $0.92 $0.84 $0.86 1 754 970
Aug 11, 2021 $0.97 $0.99 $0.88 $0.90 1 876 515
Aug 10, 2021 $1.02 $1.04 $0.96 $0.98 1 291 385
Aug 09, 2021 $1.02 $1.06 $1.01 $1.01 937 341
Aug 06, 2021 $1.02 $1.04 $1.02 $1.03 561 581
Aug 05, 2021 $1.03 $1.06 $1.02 $1.02 1 058 630
Aug 04, 2021 $1.03 $1.05 $1.01 $1.03 1 155 459
Aug 03, 2021 $1.07 $1.08 $1.03 $1.05 459 284
Aug 02, 2021 $1.08 $1.10 $1.05 $1.06 729 733
Jul 30, 2021 $1.14 $1.14 $1.07 $1.09 243 574
Jul 29, 2021 $1.12 $1.14 $1.10 $1.13 391 997
Jul 28, 2021 $1.08 $1.15 $1.07 $1.12 548 858
Jul 27, 2021 $1.08 $1.10 $1.05 $1.08 443 677
Jul 26, 2021 $1.14 $1.14 $1.09 $1.09 601 473
Jul 23, 2021 $1.10 $1.15 $1.08 $1.12 691 931
Jul 22, 2021 $1.11 $1.14 $1.08 $1.09 597 899
Jul 21, 2021 $1.04 $1.15 $1.02 $1.13 924 575
Jul 20, 2021 $1.04 $1.08 $1.02 $1.02 1 203 509
Jul 19, 2021 $1.09 $1.09 $1.02 $1.05 1 462 762
Jul 16, 2021 $1.02 $1.12 $1.02 $1.09 676 324
Jul 15, 2021 $1.07 $1.10 $1.02 $1.05 2 171 701
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT